BGB
ONCOINVENT ASA
Stock
Stock
ISIN: NO0013711713
Ticker: BGBIO
NO0013711713
BGBIO
Price
Price
CHART BY
Frequently asked questions
What is ONCOINVENT ASA's market capitalization?
The market capitalization of ONCOINVENT ASA is $20.19M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for ONCOINVENT ASA?
ONCOINVENT ASA's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$27.52. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for ONCOINVENT ASA's stock?
Currently, 1 analysts cover ONCOINVENT ASA's stock, with a consensus target price of $255.30. Analyst ratings provide insights into the stock's expected performance.
What is ONCOINVENT ASA's revenue over the trailing twelve months?
Over the trailing twelve months, ONCOINVENT ASA reported a revenue of $88.90K.
What is the EBITDA for ONCOINVENT ASA?
ONCOINVENT ASA's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$16.27M. EBITDA measures the company's overall financial performance.
What is the free cash flow of ONCOINVENT ASA?
ONCOINVENT ASA has a free cash flow of -$15.70M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does ONCOINVENT ASA have, and what sector and industry does it belong to?
ONCOINVENT ASA employs approximately 13 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of ONCOINVENT ASA's shares?
The free float of ONCOINVENT ASA is 2.93M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $20.19M
- EPS (TTM)
- -$27.52
- Free Float
- 2.93M
- Revenue (TTM)
- $88.90K
- EBITDA (TTM)
- -$16.27M
- Free Cashflow (TTM)
- -$15.70M
Pricing
- 1D span
- $4.281$4.408
- 52W span
- $4.014$98.90
Analyst Ratings
The price target is $255.30 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Oncoinvent ASA operates as a clinical-phase biotechnology company, which engages in the development of radiopharmaceutical treatment products for cancer therapy. Its focus product is Radspherin, which uses the alpha-emitting radionuclide radium-224 that targets residual micrometastases after surgery in the abdominal cavity. The company was founded by Roy H. Larsen, Øyvind Bruland, Dr. Tina Bønsdorff, and Dr. Thora Jonasdottir on December 21, 2007 and is headquartered in Oslo, Norway.
- Employees
- 13
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- NO0013711713
- Primary Ticker
- BGBIO
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet